Yijun Shen, Xiaolin Lu, Xuejun Ma, Wei Liu, Dingwei Ye. "Updated efficacy and safety results from ReBirth, a phase II study of risk-based bladder-sparing therapy for MIBC.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4586